Condition
Moderate Traumatic Brain Injury (TBI)
Total Trials
3
Recruiting
0
Active
0
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 25/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 2 (2)
Trial Status
Not Yet Recruiting2
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT07166393Phase 2Not Yet RecruitingPrimary
Valproic AcId for Traumatic BRAin INjury Trial
NCT06914310Phase 2Not Yet Recruiting
Memantine as an Additive Therapy in Patients With Traumatic Brain Injury
NCT02233413Not ApplicableCompletedPrimary
Light Therapy for Moderate Traumatic Brain Injury
Showing all 3 trials